Systematic review with meta‐analysis: Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoea

@article{Szajewska2015SystematicRW,
  title={Systematic review with meta‐analysis: Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoea},
  author={H. Szajewska and M. Kołodziej},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2015},
  volume={42}
}
Antibiotic‐associated diarrhoea is a common complication of antibiotic use, but it can be prevented with administration of probiotics. 

Topics from this paper

Systematic review with meta‐analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic‐associated diarrhoea in children and adults
The effects of probiotics are strain specific. The clinical effects of each strain need to be evaluated separately.
Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use.
TLDR
A case of fungemia in an immunocompetent patient after administration of probiotic containing Saccharomyces boulardii is reported and the safety of this preventative biotherapy is questioned. Expand
Targeting gut flora to treat and prevent disease.
There's evidence to suggest that probiotics, prebiotics, and a high-fiber diet can help mange various illnesses. Here's how to translate gut flora research into practice.
Probiotics as a Tx resource in primary care.
TLDR
While probiotics have not been marketed as drugs, clinicians can still recommend them in an evidence-based manner because they are still recommended in anEvidence-Based manner. Expand
Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial
TLDR
The effects of Lactobacillus reuteri DSM 17938 administration for the prevention of diarrhoea and AAD in children and the findings of this trial will be submitted to a peer-reviewed paediatric journal. Expand
Probiotics for antibiotic-associated diarrhea in children
TLDR
The safety profile of probiotics is excellent in healthy children; however, rare serious adverse events have been documented in severely debilitated or immunocompromised children. Expand
Probiotics for humans: Current status and future prospects
TLDR
This chapter will address the main findings of the probiotics’ administration for human, especially describing the main applications of probiotics for pregnancy, infant, children, and adult in healthy or pathological conditions. Expand
Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children.
TLDR
Recommendations are provided for the use of probiotics for the prevention of antibiotic-associated diarrhea in children based on a systematic review of previously completed systematic reviews and of randomized controlled trials published subsequently to these reviews. Expand
Probiotics and antibiotic-associated diarrhea in children: A review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment.
TLDR
Different single and multistrain probiotics are described; a specific recommendation for the use of Lactobacillus Rhamnosus GG (LGG) and Saccharomyces boulardii (Sb) emerges; new information on LGG survival under amoxicillin/clavulanate therapy in children is provided. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 61 REFERENCES
Meta‐analysis: non‐pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoea
TLDR
This work has shown that probiotic‐associated diarrhoea occurs in up to 30% of patients who receive antibiotics but can be prevented with probiotics, and this should not be considered a cause for concern. Expand
The Effect of Probiotics and Mucoprotective Agents on PPI‐Based Triple Therapy for Eradication of Helicobacter pylori
  • Min Jun Song, D. Park, +5 authors Byung Ik Kim
  • Medicine
  • Helicobacter
  • 2010
TLDR
This work evaluated the additive effects of Saccharomyces boulardii combined with proton pump inhibitor (PPI)‐based triple therapy and a mucoprotective agent coupled with PPI‐ based triple therapy for HP eradication. Expand
Efficacy and Safety of Saccharomyces boulardii in the 14‐day Triple Anti‐Helicobacter pylori Therapy: A Prospective Randomized Placebo‐Controlled Double‐Blind Study
TLDR
The aim of the study was to investigate the efficacy and safety of S. boulardii in the prevention of side‐effects related to H. pylori eradication and to define the effect ofS. Expand
Efecto del probiótico Saccharomyces boulardii en la prevención de la diarrea asociada con antibióticos en adultos ambulatorios en tratamiento con amoxicilina
TLDR
One of the alternatives suggested to prevent antibiotic-associated diarrhea is the use of the probiotic Saccharomyces boulardii, which is widely indicated inambulatory practice. Expand
Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study.
TLDR
The results implied that prophylactic use of Saccharomyces boulardii resulted in reduced, with no serious side effects, antibiotic-associated diarrhea in hospitalized patients. Expand
Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease
  • L. Mcfarland
  • Medicine
  • The American Journal of Gastroenterology
  • 2006
TLDR
Three types of probiotics (Saccharomyces boulardii, Lactobacillus rhamnosus GG, and probiotic mixtures) significantly reduced the development of antibiotic-associated diarrhea. Expand
Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis
TLDR
A systematic review and meta-analysis of randomized controlled trials of adult inpatients who were receiving antibiotics and who were randomly assigned to co-administration of probiotics or usual care, with or without the use of placebo found significant reductions in the risks of AAD and CDI. Expand
[Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment].
TLDR
Saccharomyces boulardii (500 mg/day) did not prevent diarrhea related to amoxicillin, and no adverse effects were associated to the use of the probiotic. Expand
Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis.
TLDR
The pooled evidence suggests that probiotics are associated with a reduction in AAD, and there exists significant heterogeneity in pooled results and the evidence is insufficient to determine whether this association varies systematically by population, antibiotic characteristic, or probiotic preparation. Expand
Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication
TLDR
Saccharomyces boulardii is an effective and safe treatment for prevention of antibiotic-associated diarrhoea when given concomitantly to patients receiving H. pylori eradication. Expand
...
1
2
3
4
5
...